The availability and affordability of orphan drugs for rare diseases in China

The availability and affordability of orphan drugs for rare diseases in China

Bibliographic Details
Main Authors:	Gong, Shiwei, Wang, Yingxiao, Pan, Xiaoyun, Zhang, Liang, Huang, Rui, Chen, Xin, Hu, Juanjuan, Xu, Yi, Jin, Si
Format:	Online
Language:	English
Published:	BioMed Central 2016
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769558/

Similar Items

The portal for rare diseases and orphan drugs
by: Singh, Jatinder
Published: (2013)

Orphanet: The Portal for Rare Diseases and Orphan Drugs
Published: (2009)

Rare diseases and orphan drugs: 500 years ago
by: Dooms, Marc M.
Published: (2015)

Rare diseases and orphan drugs: Latvian story
by: Logviss, Konstantins, et al.
Published: (2014)

Availability and affordability of medicines for children
by: Kazaryan, Irina, et al.
Published: (2015)

Price, availability and affordability of medicines
by: Mhlanga, Brenda S., et al.
Published: (2014)

Rare or orphan diseases: more orphan than rare in Peru
by: Frank Lizaraso Caparó, et al.
Published: (2018-08-01)

Systematic review of available evidence on 11 high-priced inpatient orphan drugs
by: Kanters, Tim A, et al.
Published: (2013)

A survey of the availability, prices and affordability of essential medicines in Jiangsu Province, China
by: Xi, Xiaoyu, et al.
Published: (2015)

Rare diseases: Canada’s “research orphans”
by: Gupta, Samir
Published: (2012)

Compassionate use of orphan drugs
by: Hyry, Hanna I., et al.
Published: (2015)

A proposed definition of rare diseases for China: from the perspective of return on investment in new orphan drugs
by: Cui, Yazhou, et al.
Published: (2015)

Medicine prices, availability and affordability in Sri Lanka
by: Senarathna, S.M.D.K. Ganga, et al.
Published: (2011)

Availability, prices and affordability of essential medicines in Haiti
by: Chahal, Harinder Singh, et al.
Published: (2013)

Availability, affordability and costs of pediatric medicines in Mongolia
by: Gereltuya Dorj, et al.
Published: (2018-05-01)

Control your mind, make affordance available
by: Jin, Zheng, et al.
Published: (2015)

Mechanism of coordinated access to orphan drugs
by: DeRidder, R, et al.
Published: (2012)

Are payers treating orphan drugs differently?
by: Cohen, Joshua P., et al.
Published: (2014)

Impact of orphan drugs on Latvian budget
by: Logviss, Konstantins, et al.
Published: (2016)

The role of globalization in drug development and access to orphan drugs: orphan drug legislation in the US/EU and in Latin America
by: Arnold, Renée J.G., et al.
Published: (2015)

Hepatitis C drug affordability
by: Mohga Kamal-Yanni
Published: (2015-02-01)

The performance and problems of affordable housing policy in China
by: Yi, Niu
Published: (2008)

Evaluating Drug Prices, Availability, Affordability, and Price Components: Implications for Access to Drugs in Malaysia
by: Babar, Zaheer Ud Din, et al.
Published: (2007)

Availability, use, and affordability of medicines in urban China under universal health coverage: an empirical study in Hangzhou and Baoji
by: Yunyu Huang, et al.
Published: (2018-03-01)

Novel orphan medicines and abandoned pathways - the US Orphan Drug Act of 1983 and the impact on rare rheumatologic diseases and lysosomal storage disorders
by: Ries, Markus, et al.
Published: (2015)

Cigarette Affordability in China, 2001-2016
by: Zheng, Rong, et al.
Published: (2017)

Distribution of affordable housing in Yinchuan, China
by: Zhang, Tao
Published: (2012)

Can China afford rapid aging?
by: Jiang, Quanbao, et al.
Published: (2016)

Some Numbers behind Canada's Decision to Adopt an Orphan Drug Policy: US Orphan Drug Approvals in Canada, 1997–2012
by: Herder, Matthew, et al.
Published: (2016)

Thirty Years of Orphan Drug Legislation and the Development of Drugs to Treat Rare Seizure Conditions: A Cross Sectional Analysis
by: Döring, Jan Henje, et al.
Published: (2016)

Measuring Access to Medicines: A Survey of Prices, Availability and Affordability in Shaanxi Province of China
by: Jiang, Minghuan, et al.
Published: (2013)

Access to Paediatric Essential Medicines: A Survey of Prices, Availability, Affordability and Price Components in Shaanxi Province, China
by: Wang, Xiao, et al.
Published: (2014)

Insulin prices, availability and affordability: a cross-sectional survey of pharmacies in Hubei Province, China
by: Chenxi Liu, et al.
Published: (2017-08-01)

Pricing and reimbursement of orphan drugs: the need for more transparency
by: Simoens, Steven
Published: (2011)

Do investors value the FDA orphan drug designation?
by: Kathleen L. Miller
Published: (2017-06-01)

Editorial: Orphan GPCRs As Emerging Drug Targets
by: Fang, Ye, et al.
Published: (2015)

Reimbursement of orphan drugs in Belgium: what (else) matters?
by: Picavet, Eline, et al.
Published: (2014)

Orphan drugs expenditure in the Netherlands in the period 2006–2012
by: Kanters, Tim A, et al.
Published: (2014)

Reimbursement of orphan drugs: the Pompe and Fabry case in the Netherlands
by: van den Brink, Rinke
Published: (2014)

Orphan drugs: pricing, reimbursement and patient access
by: Adam, Barak, et al.
Published: (2011)